The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

22 articles for N Kim


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of non-LBD inhibitor for androgen receptor by structure-guide design.EBI
Korea Research Institute of Chemical Technology
In silico identification of poly(ADP-ribose)polymerase-1 inhibitors and their chemosensitizing effects against cisplatin-resistant human gastric cancer cells.EBI
Sungkyunkwan [Corrected] University
Polyhydroxylated macrolides from Seimatosporium discosioides and their effects on the activation of peroxisome proliferator-activated receptor gamma.EBI
Korea University
Acetylenic acid analogues from the edible mushroom Chanterelle (Cantharellus cibarius) and their effects on the gene expression of peroxisome proliferator-activated receptor-gamma target genes.EBI
Korea University
Ursolic acid is a PPAR-a agonist that regulates hepatic lipid metabolism.EBI
Korea University
Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphated-ester modifications as selective agonists of the P2Y(4) receptor.EBI
Niddk
Synthesis and SAR investigations of novel 2-arylbenzimidazole derivatives as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists.EBI
Korea Research Institute of Chemical Technology
Small molecule-based reversible reprogramming of cellular lifespan.EBI
Korea Advanced Institute of Science and Technology
Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones.EBI
Harvard Medical School
Identification of Pyrido[3,4-d]pyrimidine derivatives as RIPK3-Mediated necroptosis inhibitors.EBI
Korea University
Synthesis and antibacterial activities of baulamycin A inspired derivatives.EBI
Korea University
The efficacy and cardiac evaluation of aminomethyl tetrahydronaphthalene ketopiperazines: a novel class of potent MCH-R1 antagonists.EBI
Procter & Gamble Pharmaceuticals
Aminomethyl tetrahydronaphthalene biphenyl carboxamide MCH-R1 antagonists--Increasing selectivity over hERG.EBI
Procter & Gamble Pharmaceuticals
Identification of substituted 4-aminopiperidines and 3-aminopyrrolidines as potent MCH-R1 antagonists for the treatment of obesity.EBI
Procter and Gamble Pharmaceuticals
Design and synthesis of substituted quinolines as novel and selective melanin concentrating hormone antagonists as anti-obesity agents.EBI
Procter and Gamble Pharmaceuticals
Design and synthesis of potent and selective 1,3,4-trisubstituted-2-oxopiperazine based melanocortin-4 receptor agonists.EBI
Procter & Gamble Pharmaceuticals
Identification of Pyridinyltriazine Derivatives as Potent panFGFR Inhibitors against Gatekeeper Mutants for Overcoming Drug Resistance.EBI
Korea University
Novel Macrocyclic Peptidomimetics Targeting the Polo-Box Domain of Polo-Like Kinase 1.EBI
Korea University
NOVEL COMPOUND AND USE THEREOF FOR INHIBITING CHECKPOINT KINASE 2BDB
Arum Therapeutics
PRMT5 INHIBITING COMPOUNDS AND USES THEREOFBDB
Antengene Discovery
Nitrile derivative that acts as inhibitor of dipeptidyl peptidase 1 and use thereofBDB
Haisco Pharmaceuticals